Main Article Content
Mycoplasma genitalium is recognized as an emerging sexually transmitted pathogen that is a significant cause of genital tract infections. Globally, M. genitalium prevalence estimates range between 1 and 4 percent of males and 1 and 6 percent among females. The current treatment approach to M. genitalium is discussed, including testing, treatment and management of M. genitalium infection.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.